Atrial Fibrillation New Onset Clinical Trial
Official title:
Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients (START-POAF) Pilot Trial
The START-POAF pilot study is a prospective, open-label two-arm, randomized controlled trial with blinded assessment of outcomes (PROBE). This pilot study will assess Atrial Fibrillation (AF) recurrence and burden in patients with new-onset AF following cardiac surgery.
Atrial fibrillation (AF) is the most common abnormal heart rhythm in the world. In patients who have cardiac surgery, new AF is found as an early complication in more than one out of every four surgeries. In the weeks and months after heart surgery, patients who have new AF take a medication called amiodarone to keep their heart in rhythm as it heals. If the heart goes back into AF, patients can have symptoms of heart racing, heart failure (fluid on the lungs) or stroke. Although amiodarone is effective, it can have side effects like dizziness, nausea and slow heart rate. It may also damage the lungs, liver and thyroid gland. Many patients are not able to complete their full prescribed course after surgery. Therefore, it is crucial that the investigators find the shortest possible length of treatment with amiodarone that will keep the heart in rhythm while minimizing the chance of side effects or organ damage. The START-POAF Pilot Randomized Trial will compare two different durations of amiodarone treatment: 1) in-hospital load only and 2) in-hospital load plus 4 weeks after loading dose. All participants will wear an electrocardiogram (ECG) monitor for 4 weeks the day after they complete their loading dose. The investigators will compare the amount of AF seen on the ECG between the two groups. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06055751 -
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
|
||
Recruiting |
NCT04870424 -
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
|
Phase 3 | |
Completed |
NCT05818592 -
Screening for Atrial Fibrillation With Self Pulse Monitoring
|
N/A | |
Active, not recruiting |
NCT05780320 -
A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
|
||
Active, not recruiting |
NCT03866148 -
Obstructive Sleep Apnoea and Cardiac Arrhythmias
|
N/A | |
Withdrawn |
NCT05656170 -
Stellate Ganglion to Prevent Atrial Fibrillation
|
N/A | |
Active, not recruiting |
NCT05255224 -
PARADISE: Predicting AF After Cardiac Surgery
|
||
Recruiting |
NCT04528511 -
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
|
||
Recruiting |
NCT04857268 -
Diagnostic Validation of Wearable ECG Monitoring Patch, ATP-C120
|
N/A | |
Completed |
NCT04118270 -
Shared Decision-Making: AFib 2gether Mobile App
|
N/A | |
Active, not recruiting |
NCT03345615 -
Standard Versus Intensive Monitoring After Myocardial Infarction Looking for Atrial Fibrillation
|
N/A | |
Recruiting |
NCT06275503 -
STROKESTOP III - Optimized Method for Atrial Fibrillation Screening
|
N/A | |
Recruiting |
NCT05149820 -
Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments
|
Phase 4 | |
Completed |
NCT03221777 -
Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
|
||
Not yet recruiting |
NCT03991754 -
Prevention of New Onset AF After TAVI (PAF-TAVI Trial)
|
Phase 3 | |
Completed |
NCT03118518 -
STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
|
N/A | |
Completed |
NCT03552588 -
High Sensitivity Estimate of the Incidence of Atrial Fibrillation Occurring Transiently With Stress (AFOTS Incidence Study)
|
||
Recruiting |
NCT05444335 -
Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years
|
N/A | |
Not yet recruiting |
NCT06458829 -
Promoting Atrial Fibrillation Screening in Primary Care
|
N/A | |
Terminated |
NCT05950971 -
Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation
|
N/A |